Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11499156
[patent_doc_number] => 20170073341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'Benzene Sulfonamide Thiazole and Oxazole Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/334457
[patent_app_country] => US
[patent_app_date] => 2016-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 123482
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15334457
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/334457 | Benzene Sulfonamide Thiazole and Oxazole Compounds | Oct 25, 2016 | Abandoned |
Array
(
[id] => 11568581
[patent_doc_number] => 20170107225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'HETEROARYL DERIVATIVES AS CFTR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/297983
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23075
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15297983
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/297983 | Heteroaryl derivatives as CFTR modulators | Oct 18, 2016 | Issued |
Array
(
[id] => 11851575
[patent_doc_number] => 20170226068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'PHENAZINIUM MEDIATORS'
[patent_app_type] => utility
[patent_app_number] => 15/290440
[patent_app_country] => US
[patent_app_date] => 2016-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10676
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15290440
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/290440 | Phenazinium mediators | Oct 10, 2016 | Issued |
Array
(
[id] => 11603991
[patent_doc_number] => 20170121291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 15/290918
[patent_app_country] => US
[patent_app_date] => 2016-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89002
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15290918
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/290918 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | Oct 10, 2016 | Abandoned |
Array
(
[id] => 15540703
[patent_doc_number] => 10570116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => 1,4-dicarbonyl-piperidyl derivatives
[patent_app_type] => utility
[patent_app_number] => 15/772587
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20855
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772587
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/772587 | 1,4-dicarbonyl-piperidyl derivatives | Oct 6, 2016 | Issued |
Array
(
[id] => 11851629
[patent_doc_number] => 20170226121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'MODULATORS OF VIRUS ASSEMBLY AS ANTIVIRAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/287593
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10774
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287593
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287593 | MODULATORS OF VIRUS ASSEMBLY AS ANTIVIRAL AGENTS | Oct 5, 2016 | Abandoned |
Array
(
[id] => 16756535
[patent_doc_number] => 10975071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Inhibitors of KRAS G12C mutant proteins
[patent_app_type] => utility
[patent_app_number] => 15/764097
[patent_app_country] => US
[patent_app_date] => 2016-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29341
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764097
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764097 | Inhibitors of KRAS G12C mutant proteins | Sep 27, 2016 | Issued |
Array
(
[id] => 11395137
[patent_doc_number] => 20170015671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE'
[patent_app_type] => utility
[patent_app_number] => 15/268246
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51738
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/268246 | INHIBITORS OF BRUTON'S TYROSINE KINASE | Sep 15, 2016 | Abandoned |
Array
(
[id] => 11499168
[patent_doc_number] => 20170073353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/266473
[patent_app_country] => US
[patent_app_date] => 2016-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62433
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15266473
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/266473 | SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE | Sep 14, 2016 | Abandoned |
Array
(
[id] => 11491402
[patent_doc_number] => 20170065586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'SGC STIMULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/266021
[patent_app_country] => US
[patent_app_date] => 2016-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55634
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15266021
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/266021 | SGC STIMULATORS | Sep 14, 2016 | Abandoned |
Array
(
[id] => 12085951
[patent_doc_number] => 09839664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-12
[patent_title] => 'GLP-1 receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 15/263637
[patent_app_country] => US
[patent_app_date] => 2016-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46221
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15263637
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/263637 | GLP-1 receptor modulators | Sep 12, 2016 | Issued |
Array
(
[id] => 11364000
[patent_doc_number] => 20170001981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH'
[patent_app_type] => utility
[patent_app_number] => 15/263041
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61473
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15263041
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/263041 | SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | Sep 11, 2016 | Abandoned |
Array
(
[id] => 13672587
[patent_doc_number] => 20160375027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => PROTEIN KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/262193
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/262193 | Protein kinase inhibitors | Sep 11, 2016 | Issued |
Array
(
[id] => 11844526
[patent_doc_number] => 09732070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Protein kinase C inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/261294
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78361
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15261294
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/261294 | Protein kinase C inhibitors and uses thereof | Sep 8, 2016 | Issued |
Array
(
[id] => 11542587
[patent_doc_number] => 20170096413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS HDAC6 SELECTIVE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/260855
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12869
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260855 | Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors | Sep 8, 2016 | Issued |
Array
(
[id] => 13139705
[patent_doc_number] => 10087173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication
[patent_app_type] => utility
[patent_app_number] => 15/258393
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16149
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258393
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258393 | Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication | Sep 6, 2016 | Issued |
Array
(
[id] => 12302463
[patent_doc_number] => 09937175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Phenyloxadiazole derivatives as PGDS inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/258892
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10785
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258892
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258892 | Phenyloxadiazole derivatives as PGDS inhibitors | Sep 6, 2016 | Issued |
Array
(
[id] => 11814846
[patent_doc_number] => 09718788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Heteroaryl compounds useful as inhibitors of E1 activating enzymes'
[patent_app_type] => utility
[patent_app_number] => 15/249851
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73011
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/249851 | Heteroaryl compounds useful as inhibitors of E1 activating enzymes | Aug 28, 2016 | Issued |
Array
(
[id] => 11323765
[patent_doc_number] => 20160354374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 15/241232
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57542
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/241232 | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith | Aug 18, 2016 | Issued |
Array
(
[id] => 14777849
[patent_doc_number] => 20190263822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/314364
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314364 | Pyrazolo [3,4-d] pyrimidine derivative | Aug 15, 2016 | Issued |